Natco Pharma surges 12.68% in seven sessions

Natco Pharma rose 2.9% to Rs 1,052 at 10:18 IST on BSE, with the stock extending recent strong gains.

Meanwhile, the S&P BSE Sensex was down 55.08 points, or 0.18% at 31,158.28.

On the BSE, 34,000 shares were traded on the counter so far as against the average daily volumes of 34,331 shares in the past one quarter. The stock had hit a high of Rs 1,054 so far during the day which is also its record high. The stock hit a low of Rs 1,028 so far during the day. The stock had hit a 52-week low of Rs 494 on 20 June 2016.

The stock had outperformed the market over the past one month till 8 June 2017, advancing 12.62% compared with the Sensex's 4.3% rise. The scrip had also outperformed the market over the past one quarter gaining 30.11% as against the Sensex's 8% rise. The scrip had also outperformed the market over the past one year advancing 97.56% as against the Sensex's 15.52% rise.

The large-cap company has equity capital of Rs 34.86 crore. Face value per share is Rs 2.

Shares of Natco Pharma surged 12.68% in seven trading sessions to its current ruling price of Rs 1,052, from a close of Rs 933.65 on 31 May 2017.

Natco Pharma's consolidated net profit spurted 181.4% to Rs 176.70 crore on 46.5% increase in net sales to Rs 577.80 crore in Q4 March 2017 over Q4 March 2016.

Natco Pharma manufactures generic dosage forms, bulk actives and intermediates for the Indian and international markets.

Powered by Capital Market - Live News